Piper Sandler analyst Edward Tenthoff downgraded Agile Therapeutics (NASDAQ: AGRX) from Overweight to Neutral with a price target of $303.00 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE